affinity 发表于 2025-3-26 22:30:12

Submitted on: 09 September 2024.
Revised on: 20 November 2024.
Accepted on: 20 December 2024.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

NAUT 发表于 2025-3-27 04:00:40

Submitted on: 28 February 2002.
Revised on: 18 April 2002.
Accepted on: 09 June 2002.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

遵循的规范 发表于 2025-3-27 09:21:54

Submitted on: 05 August 2002.
Revised on: 14 November 2002.
Accepted on: 06 December 2002.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

indicate 发表于 2025-3-27 10:47:46

Submitted on: 01 April 2020.
Revised on: 01 July 2020.
Accepted on: 21 August 2020.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

语言学 发表于 2025-3-27 16:45:08

Submitted on: 09 September 2012.
Revised on: 06 January 2013.
Accepted on: 31 January 2013.

___________________DRUGS IN R&D---SPRINGER INT PUBL AG

integrated 发表于 2025-3-27 19:34:22

http://reply.papertrans.cn/1/77/7678/7678-36.png
页: 1 2 3 [4]
查看完整版本: SCIE期刊DRUGS IN R&D 2024/2025影响因子:2.237 (DRUGS R&D) (1174-5886). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index